1. Sung, H, Ferlay, J, Siegel, RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-249.
Google Scholar | Crossref | Medline2. Iraqi Cancer Registery in yearly 2021, Annual report . Baghdad, Iraq: Iraqi Cancer Board, Iraqi Ministry of Health, https://moh.gov.iq/upload/upfile/ar/106def1.pdf
Google Scholar3. Rudolph, A, Chang-Claude, J, Schmidt, MK. Gene–environment interaction and risk of breast cancer. Br J Cancer. 2016;114:125.
Google Scholar | Crossref | Medline4. Jemal, A, Siegel, R, Xu, J, Ward, E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
Google Scholar | Crossref | Medline | ISI5. Croom, E. Metabolism of xenobiotics of human environments. Prog Mol Biol Transl Sci. 2012;112:31-88.
Google Scholar | Crossref | Medline6. Harris, EER . Precision medicine for breast cancer: the paths to truly individualized diagnosis and treatment. Int J Breast Cancer. 2018;2018:4809183.
Google Scholar | Crossref | Medline7. Lee, A, Mavaddat, N, Wilcox, AN, et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med. 2019;21:1708-1718.
Google Scholar | Crossref | Medline8. Maisonneuve, P, Disalvatore, D, Rotmensz, N, et al. Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes. Breast Cancer Research. 2014;16:R65.
Google Scholar | Crossref | Medline9. Sneha, S, Baker, SC, Green, A, et al. Intratumoural cytochrome P450 expression in breast cancer: impact on standard of care treatment and new efforts to develop tumour-selective therapies. Biomedicines. 2021;9:290.
Google Scholar | Crossref | Medline10. Manikandan, P, Nagini, S. Cytochrome P450 structure, function and clinical significance: a review. Curr Drug Targets. 2018;19:38-54.
Google Scholar | Crossref | Medline11. Berrandou, T, Mulot, C, Cordina-Duverger, E, et al. Association of breast cancer risk with polymorphisms in genes involved in the metabolism of xenobiotics and interaction with tobacco smoking: a gene-set analysis. Int J Cancer. 2019;144:1896-1908.
Google Scholar | Crossref | Medline12. Paracchini, V, Raimondi, S, Gram, IT, et al. Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review. Am J Epidemiol. 2007;165:115-125.
Google Scholar | Crossref | Medline | ISI13. Watanabe, J, Shimada, T, Gillam, EM, et al. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics. 2000;10:25-33.
Google Scholar | Crossref | Medline14. Ghisari, M, Eiberg, H, Long, M, Bonefeld-Jørgensen, EC. Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women. Environ Health. 2014;13:19.
Google Scholar | Crossref | Medline | ISI15. Guengerich, FP, Shimada, T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol. 1991;4:391-407.
Google Scholar | Crossref | Medline | ISI16. Sutter, TR, Tang, YM, Hayes, CL, et al. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem. 1994;269:13092-13099.
Google Scholar | Crossref | Medline | ISI17. Shimada, T, Fujii-Kuriyama, Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and1B1. Cancer Sci. 2004;95:1-6.
Google Scholar | Crossref | Medline18. Ding, M, Duan, X, Feng, X, Wang, P, Wang, W. Application of CRS-PCR-RFLP to identify CYP1A1 gene polymorphism. J Clin Lab Anal. 2017;31:e22149.
Google Scholar | Crossref19. Ewa, B, Danuta, MŠ. Polycyclic aromatic hydrocarbons and PAH-related DNA adducts. J Appl Genet. 2017;58:321-330.
Google Scholar | Crossref | Medline20. Corchero, J, Pimprale, S, Kimura, S, Gonzalez, FJ. Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics. 2001;11:1-6.
Google Scholar | Crossref | Medline21. Wen, CJ, Wu, LX, Fu, LJ, et al. Preferential induction of CYP1A1 over CYP1B1 in human breast cancer MCF-7 cells after exposure to berberine. Asian Pac J Cancer Prev. 2014;15:495-499.
Google Scholar | Crossref | Medline22. Qiu, J, Du, Z, Liu, J, Zhou, Y, Liang, F, Lü, Q. Association between polymorphisms in estrogen metabolism genes and breast cancer development in Chinese women: a prospective case–control study. Medicine. 2018;97:e13337.
Google Scholar | Crossref23. Masson, LF, Sharp, L, Cotton, SC, Little, J. Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a huge review. Am J Epidemiol. 2005;161:901-915.
Google Scholar | Crossref | Medline24. Boyapati, SM, Shu, XO, Gao, YT, Cai, Q, Jin, F, Zheng, W. Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women. Cancer. 2005;103:2228-2235.
Google Scholar | Crossref | Medline | ISI25. Yao, L, Fang, F, Wu, Q, Zhong, Y, Yu, L. No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects. Breast Cancer Res Treat. 2010;122:237-242.
Google Scholar | Crossref | Medline26. Gajjar, K, Martin-Hirsch, PL, Martin, FL. CYP1B1 and hormone-induced cancer. Cancer Letters. 2012;324:13-30.
Google Scholar | Crossref | Medline | ISI27. Vinothini, G, Nagini, S. Correlation of xenobiotic-metabolizing enzymes, oxidative stress and NFκB signaling with histological grade and menopausal status in patients with adenocarcinoma of the breast. Clinica Chimica Acta. 2010;411:368-374.
Google Scholar | Crossref | Medline28. Brockdorff, BL, Skou, J, Reiter, BE, Lykkesfeldt, AE. Increased expression of cytochrome p450 1A1 and 1B1 genes in anti-estrogen-resistant human breast cancer cell lines. Int J Cancer. 2000;88:902-906.
Google Scholar | Crossref | Medline29. Mohammed, AF. Pollution caused by vehicle exhausts and oil trash burning in Kirkuk city. Iraqi Natl J Earth Sci. 2009;9:39-48.
Google Scholar30. Al-Dabbas, MA, Ali, LA, Afaj, AH. Determination of heavy metals and polycyclic aromatic hydrocarbon concentrations in soil and in the leaves of plant (Eucalyptus) of selected locations at Kirkuk – Iraq. Arab J Geosci. 2015;8:3743-3753.
Google Scholar | Crossref31. Al- Dabbas, MA, Ali, LA, Afaj, AH. Determination of total suspended particles and the polycyclic aromatic hydrocarbons concentrations in air of selected locations at Kirkuk, Iraq. Arab J Geosci. 2015;8:335-343.
Google Scholar | Crossref32. Mohammed, AB, Goran, SM, Tarafdar, A. Profiling of seasonal variation in and cancer risk assessment of benzo (a) pyrene and heavy metals in drinking water from Kirkuk city, Iraq, 2021. https://europepmc.org/article/ppr/ppr320210
Google Scholar33. Bonner, MR, Han, D, Nie, J, et al. Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev. 2005;14:53-60.
Google Scholar | Medline | ISI34. Mordukhovich, I, Rossner, P, Terry, MB, et al. Associations between polycyclic aromatic hydrocarbon–related exposures and p53 mutations in breast tumors. Environ Health Perspect. 2010;118:511-518.
Google Scholar | Crossref | Medline35. Brody, JG, Rudel, RA. Environmental pollutants and breast cancer. Environ Health Perspect. 2003;111:1007-1019.
Google Scholar | Crossref | Medline36. Large, C, Wei, Y. Geographic variations in female breast cancer incidence in relation to ambient air emissions of polycyclic aromatic hydrocarbons. Environ Sci Pollut Res Int. 2017;24:17874-17880.
Google Scholar | Crossref | Medline37. Amin, MB, Greene, FL, Edge, SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more ‘personalized’ approach to cancer staging. CA Cancer J Clin. 2017;67:93-99.
Google Scholar | Crossref | Medline | ISI38. den Dunnen, JT, Dalgleish, R, Maglott, DR, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37:564-569.
Google Scholar | Crossref | Medline39. Vijayalakshmi, K, Vettriselvi, V, Krishnan, M, Shroff, S, Jayanth, VR, Paul, SF. Cytochrome p4501A1 gene variants as susceptibility marker for prostate cancer. Cancer Biomark. 2005;1:251-258.
Google Scholar | Crossref | Medline40. Gehan, A, El-Shennawy, A-AAE, Isamil, AE, Elbehery, MM. Is Genetic polymorphism of ESR1, CYP1A1 and CYP1B1 risk factor for development of uterine leiomyoma. Egypt J Med Microbiol. 2010;19:19-26.
Google Scholar41. Cappelletti, V, Iorio, E, Miodini, P, Silvestri, M, Dugo, M, Daidone, MG. Metabolic footprints and molecular subtypes in breast cancer. Dis Markers. 2017;2017:7687851.
Google Scholar | Crossref | Medline42. Zhang, Y, Wise, JP, Holford, TR, et al. Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in connecticut women. Am J Epidemiol. 2004;160:1177-1183.
Google Scholar | Crossref | Medline43. Li, Y, Millikan, RC, Bell, DA, et al. Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study. Breast Cancer Res. 2005;7:R12-R18.
Google Scholar44. Nebert, DW, Dalton, TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer. 2006;6:947-960.
Google Scholar | Crossref | Medline | ISI45. Wielsøe, M, Eiberg, H, Ghisari, M, Kern, P, Lind, O, Bonefeld-Jørgensen, EC. Genetic variations, exposure to persistent organic pollutants and breast cancer risk – a greenlandic case–control study. Basic Clin Pharmacol Toxicol. 2018;123:335-346.
Google Scholar | Crossref | Medline46. Hoidy, WH, Jaber, FA, Al-Askari, MA. Association of CYP1A1 rs1048943 polymorphism with prostate cancer in Iraqi men patients. Asian Pac J Cancer Prev. 2019;20:3839-3842.
Google Scholar | Crossref | Medline47. Abdul-Jabbar, RA-A, Shanyoor, GJ. Polymorphism of CYP1A1 gene and the variation in rs4646903, rs1048943 that occurs of cervical cancer in Iraq. Ann Roman Soc Cell Biol. 2021;25: 8143-8147.
Google Scholar48. Kudhair, BK, Lafta, IJ, Alabid, NN. Waterpipe tobacco smoking and gene variants of CYP1A1-Ile462Val and -MspI polymorphisms are possibly associated with the risk of lung cancer in the Iraqi population. Meta Gene. 2020;23:100623.
Google Scholar | Crossref49. Hussain, T, Alrokayan, S, Upasna, U, et al. Meta-analysis of genetic polymorphisms in xenobiotic metabolizing enzymes and their association with breast cancer risk. J Genet. 2018;97:523-537.
Google Scholar | Crossref | Medline50. Pabalan, N, Singh, N, Singian, E, Barbosa, C, Bianco, B, Jarjanazi, H. Associations of CYP1A1 gene polymorphisms and risk of breast cancer in Indian women: a meta-analysis. AIMS Genet. 2015;2:250-262.
Google Scholar | Crossref51. Li, Y, Millikan, RC, Bell, DA, et al. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women. Breast Cancer Res. 2004;6:R460-R473.